BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32578942)

  • 1. Innovations, challenges, and minimal information for standardization of humanized mice.
    Stripecke R; Münz C; Schuringa JJ; Bissig KD; Soper B; Meeham T; Yao LC; Di Santo JP; Brehm M; Rodriguez E; Wege AK; Bonnet D; Guionaud S; Howard KE; Kitchen S; Klein F; Saeb-Parsy K; Sam J; Sharma AD; Trumpp A; Trusolino L; Bult C; Shultz L
    EMBO Mol Med; 2020 Jul; 12(7):e8662. PubMed ID: 32578942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial.
    Brendel C; Rio P; Verhoeyen E
    Biochem Pharmacol; 2020 Apr; 174():113711. PubMed ID: 31726047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized Mice as Unique Tools for Human-Specific Studies.
    Yong KSM; Her Z; Chen Q
    Arch Immunol Ther Exp (Warsz); 2018 Aug; 66(4):245-266. PubMed ID: 29411049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanized mouse models: Application to human diseases.
    Ito R; Takahashi T; Ito M
    J Cell Physiol; 2018 May; 233(5):3723-3728. PubMed ID: 28598567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
    Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
    Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologously Humanized Mice for Immune-Oncologic Studies.
    Fu J; Kim YJ
    Curr Protoc Pharmacol; 2020 Jun; 89(1):e76. PubMed ID: 32469451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
    Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and Characterization of a Humanized Lung Xenograft Mouse Model for Studying Henipavirus Pathogenesis.
    Valbuena G; Rockx B; Escaffre O
    Methods Mol Biol; 2023; 2682():191-204. PubMed ID: 37610583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology.
    Yao LC; Aryee KE; Cheng M; Kaur P; Keck JG; Brehm MA
    Methods Mol Biol; 2019; 1953():241-252. PubMed ID: 30912026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humanized mice as preclinical models for myeloid malignancies.
    Gbyli R; Song Y; Halene S
    Biochem Pharmacol; 2020 Apr; 174():113794. PubMed ID: 31926939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the BLT humanized mouse as a stem cell based gene therapy tumor model.
    Vatakis DN; Bristol GC; Kim SG; Levin B; Liu W; Radu CG; Kitchen SG; Zack JA
    J Vis Exp; 2012 Dec; (70):e4181. PubMed ID: 23271478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanized Severe Combined Immunodeficient (SCID) Mouse Models for Varicella-Zoster Virus Pathogenesis.
    Lloyd MG; Moffat JF
    Curr Top Microbiol Immunol; 2023; 438():135-161. PubMed ID: 35292858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling EBV infection and pathogenesis in new-generation humanized mice.
    Fujiwara S; Imadome K; Takei M
    Exp Mol Med; 2015 Jan; 47(1):e135. PubMed ID: 25613732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
    Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
    J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized Mouse Models for Immuno-oncology Drug Discovery.
    Kumari R; Feuer G; Bourré L
    Curr Protoc; 2023 Aug; 3(8):e852. PubMed ID: 37552031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanized Mouse Models of Clinical Disease.
    Walsh NC; Kenney LL; Jangalwe S; Aryee KE; Greiner DL; Brehm MA; Shultz LD
    Annu Rev Pathol; 2017 Jan; 12():187-215. PubMed ID: 27959627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Applications and Perspectives of Humanized Mouse Models.
    Ye W; Chen Q
    Annu Rev Anim Biosci; 2022 Feb; 10():395-417. PubMed ID: 34758273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer: Authenticate new xenograft models.
    Nardone RM; MacLeod RA; Capes-Davis A
    Nature; 2016 Apr; 532(7599):313. PubMed ID: 27127813
    [No Abstract]   [Full Text] [Related]  

  • 19. Humanized mouse models for immuno-oncology research.
    Chuprin J; Buettner H; Seedhom MO; Greiner DL; Keck JG; Ishikawa F; Shultz LD; Brehm MA
    Nat Rev Clin Oncol; 2023 Mar; 20(3):192-206. PubMed ID: 36635480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
    Okada S; Vaeteewoottacharn K; Kariya R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.